Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Theranostics|March 21, 2018
The role of PTRF/Cavin1 as a biomarker in both glioma and serum exosomesKai Huang, Chuan Fang, Kaikai Yi, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 28, 2022
Glioma-derived exosomes hijack the blood-brain barrier to facilitate nanocapsule delivery via LCN2Chao Yang, Ye Wu, Lin Wang, et al.
Advanced Materials (Deerfield Beach, Fla.)|November 12, 2019
Dual-Locking Nanoparticles Disrupt the PD-1/PD-L1 Pathway for Efficient Cancer ImmunotherapyZhanzhan Zhang, Qixue Wang, Qi Liu, et al.
Frontiers in Oncology|May 16, 2022
lncRNA PRADX is a Mesenchymal Glioblastoma Biomarker for Cellular Metabolism Targeted TherapyCan Xu, Jixing Zhao, Jia Song, et al.
Acta Pharmaceutica Sinica. B|July 23, 2025
Linagliptin synergizes with cPLA2 inhibition to enhance temozolomide efficacy by interrupting DPP4-mediated EGFR stabilization in gliomaDongyuan Su, Biao Hong, Shixue Yang, et al.
Theranostics|August 2, 2019
A Compound AC1Q3QWB Selectively Disrupts HOTAIR-Mediated Recruitment of PRC2 and Enhances Cancer Therapy of DZNepYansheng Li, Yu Ren, Yunfei Wang, et al.
Theranostics|October 4, 2018
Mesenchymal glioblastoma constitutes a major ceRNA signature in the TGF-β pathwayQixue Wang, Jinquan Cai, Chuan Fang, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 2019
Elevated signature of a gene module coexpressed with CDC20 marks genomic instability in gliomaYunqiu Zhang, Jiuyi Li, Kaikai Yi, et al.
Cancer Communications (London, England)|November 3, 2023
Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastomaXiaoteng Cui, Jixing Zhao, Guanzhang Li, et al.
Neuro-Oncology|August 31, 2023
EPIC-1042 as a potent PTRF/Cavin1-caveolin-1 interaction inhibitor to induce PARP1 autophagic degradation and suppress temozolomide efflux for glioblastomaBiao Hong, Eryan Yang, Dongyuan Su, et al.
Pageof 4